透過您的圖書館登入
IP:3.143.228.40
  • 期刊
  • OpenAccess

血管張力素抑制劑改善心肌梗塞後心臟功能以及減少再塑形

Improved Left Ventricular Function and Reduction of Remodeling After Angiotension-Converting Enzyme Inhibitiors Therapy in Acute Myocardial Infarction

摘要


The purpose of this study was to evaluate the left ventricular global function and regional wall motion in patients with acute myocardial infarction MI after angiotension converting enzyme inhibitors treatment. Thirty-seven patients were enrolled in this study, aged 39 to 70 yr old. Seventeen cases of acute anteroseptal myocardial infarction (MI) received captopril 50 mg twice a day [the initial dose was 12.5 mg], as soon as possible MI. Two cases were withdrawed due to hypotension after therapy, and 3 cases were withdrawed due to severe cough after therapy. Twelve cases were randomly selected to be the control (conservative treatment). In the captopril group, 8 cases received percuttaneous transluminal coronary angioplasty (PTCA) later. In the control group, 12 cases received PTCA. Follow-up intravenous and/or intraventricular left cine-ventriculography, as well as radionuchlide ejection fraction were performed 6-12 months after the acute phase. The captopril group had a significant greater increase of ejection fraction by both the radionuclide (21±1.1 vs 5±0.6, P<0.05) and intravenous (24±0.9% vs 6±9.5, P<0.05) left ventriculography than the control group. There were no significant changes in the dyskinetic area, volume, and left ventricular circumference, between the 2 groups. The conclusion is that coptopril per os can improved the left ventricular function and prevent the remodeling and dilatation of It ventricle after acute myocardial infarction.

並列摘要


The purpose of this study was to evaluate the left ventricular global function and regional wall motion in patients with acute myocardial infarction MI after angiotension converting enzyme inhibitors treatment. Thirty-seven patients were enrolled in this study, aged 39 to 70 yr old. Seventeen cases of acute anteroseptal myocardial infarction (MI) received captopril 50 mg twice a day [the initial dose was 12.5 mg], as soon as possible MI. Two cases were withdrawed due to hypotension after therapy, and 3 cases were withdrawed due to severe cough after therapy. Twelve cases were randomly selected to be the control (conservative treatment). In the captopril group, 8 cases received percuttaneous transluminal coronary angioplasty (PTCA) later. In the control group, 12 cases received PTCA. Follow-up intravenous and/or intraventricular left cine-ventriculography, as well as radionuchlide ejection fraction were performed 6-12 months after the acute phase. The captopril group had a significant greater increase of ejection fraction by both the radionuclide (21±1.1 vs 5±0.6, P<0.05) and intravenous (24±0.9% vs 6±9.5, P<0.05) left ventriculography than the control group. There were no significant changes in the dyskinetic area, volume, and left ventricular circumference, between the 2 groups. The conclusion is that coptopril per os can improved the left ventricular function and prevent the remodeling and dilatation of It ventricle after acute myocardial infarction.

延伸閱讀